Published April 3, 2013 by Legal Examiner The U.S. Food and Drug Administration OKd Feb. 1 adding “diabetes mellitus” to the safety labeling of Zoloft (sertraline), a selective serotonin reuptake inhibitor antidepressant. The chronic condition appears under “Other Events Observed During the Post-marketing Evaluation” of Zoloft, which, for the time being, does not mean that […]
The post SSRI Antidepressants Including Zoloft Link to Baby Birth Defects appeared first on .
